Zhao, Q., Manning, J. R., Sutton, J., Costales, A., Sendzik, M., Shafer, C. M., . . . Pagliarini, R. (2018). Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors. ACS Med Chem Lett.
Chicago Style CitationZhao, Qian, et al. "Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones As Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors." ACS Med Chem Lett 2018.
MLA CitationZhao, Qian, et al. "Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones As Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors." ACS Med Chem Lett 2018.
Warning: These citations may not always be 100% accurate.